Dominika Lukovic
Overview
Explore the profile of Dominika Lukovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Han E, Muller-Zlabinger K, Hasimbegovic E, Poschenreithner L, Kastner N, Maleiner B, et al.
Biomolecules
. 2025 Feb;
15(2).
PMID: 40001603
Endothelial dysfunction mediated by elevated levels of autoantibodies against vasoactive peptides occurring after COVID-19 infection is proposed as a possible pathomechanism for orthostatic intolerance in long COVID patients. This case-control...
2.
Nagy R, Makkos A, Baranyai T, Giricz Z, Szabo M, Kravcsenko-Kiss B, et al.
Br J Pharmacol
. 2024 Sep;
182(2):396-416.
PMID: 39294819
Background And Purpose: Cardioprotective miRNAs (protectomiRs) are promising therapeutic tools. Here, we aimed to identify protectomiRs in a translational porcine model of acute myocardial infarction (AMI) and to validate their...
3.
Hamzaraj K, Han E, Hasimbegovic E, Poschenreiter L, Vavrikova A, Lukovic D, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932339
Patients with long COVID syndrome present with various symptoms affecting multiple organs. Vaccination before or after SARS-CoV-2 infection appears to reduce the incidence of long COVID or at least limit...
4.
Lukovic D, Gyongyosi M, Pavo I, Mester-Tonczar J, Einzinger P, Zlabinger K, et al.
Basic Res Cardiol
. 2024 Jun;
119(5):807-829.
PMID: 38922408
Combined [F]FDG PET-cardiac MRI imaging (PET/CMR) is a useful tool to assess myocardial viability and cardiac function in patients with acute myocardial infarction (AMI). Here, we evaluated the prognostic value...
5.
Mester-Tonczar J, Einzinger P, Hasimbegovic E, Kastner N, Schweiger V, Spannbauer A, et al.
Biomolecules
. 2023 Dec;
13(12).
PMID: 38136582
Despite the widespread use of doxorubicin (DOX) as a chemotherapeutic agent, its severe cumulative cardiotoxicity represents a significant limitation. While the liposomal encapsulation of doxorubicin (Myocet, MYO) reduces cardiotoxicity, it...
6.
Gyongyosi M, Lukovic D, Mester-Tonczar J, Zlabinger K, Einzinger P, Spannbauer A, et al.
NPJ Vaccines
. 2023 Sep;
8(1):145.
PMID: 37773184
Epstein-Barr virus (EBV) reactivation may be involved in long-COVID symptoms, but reactivation of other viruses as a factor has received less attention. Here we evaluated the reactivation of parvovirus-B19 and...
7.
Traxler D, Dannenberg V, Zlabinger K, Gugerell A, Mester-Tonczar J, Lukovic D, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445825
Small extracellular vesicles (EVs) and their cargo are an important component of cell-to-cell communication in cardiac disease. Allogeneic adipose derived stem cells (ADSCs) are thought to be a potential approach...
8.
Lukovic D, Hasimbegovic E, Winkler J, Mester-Tonczar J, Muller-Zlabinger K, Han E, et al.
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108624
We have designed translational animal models to investigate cardiac profibrotic gene signatures. Domestic pigs were treated with cardiotoxic drugs (doxorubicin, DOX, n = 5 or Myocet, MYO, n = 5)...
9.
Hemetsberger R, Farhan S, Lukovic D, Zlabinger K, Hajagos-Toth J, Bota J, et al.
J Pers Med
. 2023 Feb;
13(2).
PMID: 36836514
(1) Background: Coronary artery stenting leads to local inflammation, disturbs vasomotion, and slows endothelialization, increasing vascular thrombus risk. We used a pig stenting coronary artery model to assess how peri-interventional...
10.
Gara E, Ong S, Winkler J, Zlabinger K, Lukovic D, Merkely B, et al.
Front Bioeng Biotechnol
. 2022 Jun;
10:767985.
PMID: 35646882
Recent preclinical investigations and clinical trials with stem cells mostly studied bone-marrow-derived mononuclear cells (BM-MNCs), which so far failed to meet clinically significant functional study endpoints. BM-MNCs containing small proportions...